AMANDA WATSON: Open Payments
NPI 1265698559 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,433 in 52 payments from 15 companies in 2025. Trend: 2023 $680 · 2024 $1,201 · 2025 $1,433
Food & beverage: $1,433
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $342 |
| Regeneron Healthcare Solutions, Inc. | 7 | $193 |
| GENZYME CORPORATION | 6 | $150 |
| Amgen Inc. | 2 | $135 |
| UCB, Inc. | 1 | $113 |
| Lilly USA, LLC | 2 | $108 |
| LEO Pharma Inc. | 4 | $100 |
| PFIZER INC. | 5 | $90 |
| Galderma Laboratories, L.P. | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
Products named: DUPIXENT, RINVOQ, OTEZLA, SKYRIZI, Bimzelx, CIBINQO, EBGLYSS, ADBRY.
Industry payments across GA — which companies pay providers there.
